Once administered, the vector instructs the body to express these viral fragments, effectively teaching T cells what to look for.
istock.com/magicmine
Papzimeos is the first FDA-approved therapy for recurrent respiratory papillomatosis, a rare…
A first-of-its-kind therapy offers a new path for hard-to-treat airway disorder
